FDA Approved: VAFSEO — Supplemental Application (Akebia Therapeutics, Inc.)

View source ↗

Summary

FDA approved a supplemental application for VAFSEO (vadadustat) from Akebia Therapeutics, Inc. under NDA 215192.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Due to Chronic Kidney Disease

Drugs mentioned

• VAFSEO (VADADUSTAT)

Snippet

SUPPL AP for VAFSEO (VADADUSTAT)